These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21831775)

  • 1. Beneficial microbes for premature infants, and children with malignancy undergoing chemotherapy.
    Yamashiro Y; Nagata S
    Benef Microbes; 2010 Nov; 1(4):357-65. PubMed ID: 21831775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial.
    Costeloe K; Bowler U; Brocklehurst P; Hardy P; Heal P; Juszczak E; King A; Panton N; Stacey F; Whiley A; Wilks M; Millar MR
    Health Technol Assess; 2016 Aug; 20(66):1-194. PubMed ID: 27594381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial.
    Mihatsch WA; Vossbeck S; Eikmanns B; Hoegel J; Pohlandt F
    Neonatology; 2010; 98(2):156-63. PubMed ID: 20234140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants.
    Lin HC; Su BH; Chen AC; Lin TW; Tsai CH; Yeh TF; Oh W
    Pediatrics; 2005 Jan; 115(1):1-4. PubMed ID: 15629973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.
    Costeloe K; Hardy P; Juszczak E; Wilks M; Millar MR;
    Lancet; 2016 Feb; 387(10019):649-660. PubMed ID: 26628328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial.
    Lin HC; Hsu CH; Chen HL; Chung MY; Hsu JF; Lien RI; Tsao LY; Chen CH; Su BH
    Pediatrics; 2008 Oct; 122(4):693-700. PubMed ID: 18829790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial.
    Sari FN; Dizdar EA; Oguz S; Erdeve O; Uras N; Dilmen U
    Eur J Clin Nutr; 2011 Apr; 65(4):434-9. PubMed ID: 21245887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of different probiotic combinations on death and necrotizing enterocolitis in a premature rat model.
    Wu SF; Chiu HY; Chen AC; Lin HY; Lin HC; Caplan M
    J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):23-8. PubMed ID: 23535766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials.
    Wang Q; Dong J; Zhu Y
    J Pediatr Surg; 2012 Jan; 47(1):241-8. PubMed ID: 22244424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics for the prevention of necrotizing enterocolitis in neonates: an 8-year retrospective cohort study.
    Li D; Rosito G; Slagle T
    J Clin Pharm Ther; 2013 Dec; 38(6):445-9. PubMed ID: 23865733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial).
    Millar M; Seale J; Greenland M; Hardy P; Juszczak E; Wilks M; Panton N; Costeloe K; Wade WG
    EBioMedicine; 2017 Jun; 20():255-262. PubMed ID: 28571671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates--a randomised double blind placebo controlled trial.
    Patole S; Keil AD; Chang A; Nathan E; Doherty D; Simmer K; Esvaran M; Conway P
    PLoS One; 2014; 9(3):e89511. PubMed ID: 24594833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants.
    Fujii T; Ohtsuka Y; Lee T; Kudo T; Shoji H; Sato H; Nagata S; Shimizu T; Yamashiro Y
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):83-8. PubMed ID: 16819382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.
    Bin-Nun A; Bromiker R; Wilschanski M; Kaplan M; Rudensky B; Caplan M; Hammerman C
    J Pediatr; 2005 Aug; 147(2):192-6. PubMed ID: 16126048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial.
    Jacobs SE; Tobin JM; Opie GF; Donath S; Tabrizi SN; Pirotta M; Morley CJ; Garland SM;
    Pediatrics; 2013 Dec; 132(6):1055-62. PubMed ID: 24249817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and three-species administration.
    Ishizeki S; Sugita M; Takata M; Yaeshima T
    Anaerobe; 2013 Oct; 23():38-44. PubMed ID: 23988359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.
    Wang C; Shoji H; Sato H; Nagata S; Ohtsuka Y; Shimizu T; Yamashiro Y
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):252-7. PubMed ID: 17255840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis.
    Chang HY; Chen JH; Chang JH; Lin HC; Lin CY; Peng CC
    PLoS One; 2017; 12(2):e0171579. PubMed ID: 28182644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.
    Braga TD; da Silva GA; de Lira PI; de Carvalho Lima M
    Am J Clin Nutr; 2011 Jan; 93(1):81-6. PubMed ID: 20980486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bifidobacterium breve M-16V supplementation on faecal bifidobacteria in growth restricted very preterm infants - analysis from a randomised trial.
    Patole SK; Keil AD; Nathan E; Doherty D; Esvaran M; Simmer KN; Conway P
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3751-5. PubMed ID: 26821074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.